Pingora Partners’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.51M Buy
89,510
+5,650
+7% +$150K 1.49% 12
2025
Q4
$2.09M Buy
83,860
+2,692
+3% +$67.9K 1.28% 13
2025
Q3
$2.07M Sell
81,168
-1,230
-1% -$30.4K 1.37% 13
2025
Q2
$2M Sell
82,398
-1,170
-1% -$27.3K 1.49% 14
2025
Q1
$2.12M Sell
83,568
-1,150
-1% -$30.1K 1.57% 10
2024
Q4
$2.25M Buy
84,718
+16,748
+25% +$454K 1.47% 10
2024
Q3
$1.97M Buy
67,970
+21,275
+46% +$621K 1.39% 9
2024
Q2
$1.31M Buy
46,695
+12,105
+35% +$333K 0.93% 22
2024
Q1
$960K Buy
34,590
+280
+0.8% +$7.77K 0.7% 30
2023
Q4
$988K Buy
+34,310
New +$1.04M 0.87% 29

Other funds holding PFE

Pingora Partners's PFE Position: Q1 2026 in Review

Pingora Partners increased its Pfizer (PFE) stake by 6.7% in Q1 2026, buying an estimated $150K and bringing the position to 89,510 shares worth $2.51M. The position accounts for 1.49% of the portfolio, ranked #12.

Pingora Partners first reported a position in PFE in Q4 2023 and has held it in 10 quarters since. 2,935 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Pingora Partners held 89,510 shares of Pfizer worth $2.51M as of Q1 2026.
  • Pingora Partners bought 5,650 Pfizer shares in Q1 2026, an estimated $150K.
  • Pfizer made up 1.49% of Pingora Partners's portfolio in Q1 2026, its #12 holding.
  • Pingora Partners first reported a position in Pfizer in Q4 2023 and has held it in 10 quarters since.
  • 2,935 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Pingora Partners's 13F filing for Q1 2026, filed 15 May 2026.